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and/or big metastatic nodes was performed with
2 Gy fractions. Total doses were the same as in
first and second group, local tumor dose was
64-72 Gy. Complete or partial regression was
more frequently registered in tirst and second
group (39%, 62% respectively). In tirst group
rate was 2%. Rate ot postirradiation
pathomorphosis ot 3-4 grade was 35% in tirst
group, 50% in second, 66% in third group. This
data shows improvement ot nearest treatment
results.
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MENINGIOMAS TREATED IN
GREATPOLAND CANCER CENTER
BETWEEN 1990-1997
G. Mróz-Bąk, A. O'5hea, D. Jezierska,
M. Kubaszewska
Greatpoland Cancer Center, Poznań
Introduction: We analyzed correlation
between age ot patient with anaplastic
meningiomas, extension ot tumor excision,
histopatological recognition and time to
recurrence and survival.
Material and methods: Between 1990-1997
7 patients with anaplastic meningioma, 3
patients with haemangiopericytoma, 2 patients
with sarcoma meningeum (6 women and 6 men)
have been irradiated. 7 patients underwent
radical excision ot the tumor, 5 patients non
radical. The patients were irradiated trom Iimited
tields to total dose 56-60 Gy/T mostly by energy
Co-60 (9 patients) and photons 9MV (3
patients).
Results: There are 6 patients with
anaplasticum meningioma stilI alive. 3 patients
living 96·108 months, 3 other 30-39 months.
Recurrence was contirmed in two male
participants who underwent radical surgery in 12
and 29 month trom the start ot treatment. The
tirst patient died after 16 months with recurrence
ot the disease. One patient (39 years old) with
heamangiopericytoma Iives 40 months after
radical surgery without evidence ot recurrence.
Two patients died - one 11 months after radical
surgery (41 years old) and the other one (42
years old) 21 months after non radical surgery.
Both patients (24 and 59 years old) with
sarcoma died (one after 8 months, and the other
one after 21 months).
Conclusions: Patient with anaplastic
meningiomas have long survival. The extension
ot tumor excision didn't influence on survival.
Rep. Pract. Oncol. Radiołher. 6 (1) 2001
71.
THE RESULTS OF POSTOPERATIVE
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TREATED IN GREATPOLAND
CANCER CENTER
G. Mróz-Bąk, M. Dymnicka,T. Piotrowski,
M. Kubaszewska
Greatpoland Cancer Center, First Radiotherapy
Department, Medical Physics Department
Introduction: Low-grade glicomas represents
15% of aU primary brain tumors.
Material and Method: Between 1990-97 63
patient with low-grade gliomas were treated in
Greatpoland Cancer Center (39 males, 24
females; age between 20-60 year). 15 patients
had andegrone complete surgical excision, 48
partialor subtotal excision ot tumor. The trontal
lobe was affected in 33 patients, the temporai
lobe in 14 patients. Patients received
conventional irradiaton ot 60Gy.
Results: *Five patients with histologically
verified pilocytic astrocytomas(l) were treated
after partial excision, median of age 29.2year
median survival 58 months(27-108) Only one
patient died 27months after radiotherapy.
*Thirteen patients with fibrylar astrocytomas(II)-
11 post subtotal excision-median age 37.7year
median survival 32.5months. Recurrent tumor in
two patients. Five patients are alive. *Ten
patients with protoplasmatic astrocytoma(II)-7
post subtotal excision median ot age 43.5year
median survivaI30.8months. Four patients alive.
*Seven patients with gemistocytic
astrocytomas(ll) (6 post subtotal excision)-
median age 36year, median survival 32months.
Only one patient alive. *Eleven patients with
0Iigoastrocytomas(II)-11 post subtotal excision,
median age 38.6 year, median survival
43.9months. Two patients with recrrent tumor.
Alive 8 patients. *Seventeen patients with
oligodendrogliomas (11 post subtotal excision)
median age 39 years, median survival
39months. One patien with recrrent tumor. Alive
8 patients.
Conclusions: *30 patients are alive(48%);
*histopathologic diagnosis pilocytic
astrocytomas asociated with age 10 years
younger then either low-grade gliomas and long-
term survivors; *poor prognistic tactor in
gemistocytic astrocytomas-only one patient
alive;*five patients with recurrent tumor among
17 to 49 months after radiotheraphy.
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